Page last updated: 2024-09-03

pramipexole and salmeterol xinafoate

pramipexole has been researched along with salmeterol xinafoate in 2 studies

Compound Research Comparison

Studies (pramipexole)	Trials (pramipexole)	Recent Studies (post-2010) (pramipexole)	Studies (salmeterol xinafoate)	Trials (salmeterol xinafoate)	Recent Studies (post-2010) (salmeterol xinafoate)
1,103	219	517	46	0	25
1,103	219	517	1,872	684	398

Protein Interaction Comparison

Protein	Taxonomy	salmeterol xinafoate (IC50)
Beta-2 adrenergic receptor	Homo sapiens (human)	0.005
Beta-1 adrenergic receptor	Homo sapiens (human)	0.5012
Beta-2 adrenergic receptor	Cavia porcellus (domestic guinea pig)	0.0035

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gmeiner, P; Hübner, H; Stanek, M; Weichert, D	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1

Other Studies

2 other study(ies) available for pramipexole and salmeterol xinafoate

Article	Year
Structure-guided development of dual β2 adrenergic/dopamine D2 receptor agonists. Bioorganic & medicinal chemistry, 2016, 06-15, Volume: 24, Issue:12 Topics: Adrenergic beta-2 Receptor Agonists; Animals; Benzoxazines; CHO Cells; Cricetulus; Dopamine Agonists; Drug Discovery; HEK293 Cells; Humans; Models, Molecular; Parkinson Disease; Polypharmacology; Receptors, Adrenergic, beta-2; Receptors, Dopamine D2	2016
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013

Article

Year

Structure-guided development of dual β2 adrenergic/dopamine D2 receptor agonists.

Bioorganic & medicinal chemistry, 2016, 06-15, Volume: 24, Issue:12

Topics: Adrenergic beta-2 Receptor Agonists; Animals; Benzoxazines; CHO Cells; Cricetulus; Dopamine Agonists; Drug Discovery; HEK293 Cells; Humans; Models, Molecular; Parkinson Disease; Polypharmacology; Receptors, Adrenergic, beta-2; Receptors, Dopamine D2

2016

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013